CD14 and inflammatory bowel disease: MDSC are increased in the peripheral blood of IBD patients [85, 86]; CD14+HLA-DR-/lo monocytic MDSC have the ability to suppress T cell proliferation [85], while CD33+CD15+ granulocytic MDSC fail to suppress T cell response but instead enhance T cell proliferation [86].